Skip to main content

Palisade Bio, Inc.

PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001357459

In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Palisade Bio, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of PALI: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3312−21
Shares8.40M124.7K−8.28M (−98.5%)
Value$842.0K$648.0K−$194.0K (−23.0%)

New holders (2)

Institutions that held Palisade Bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to PALI in Q4 2022
InstitutionSharesValue% of portfolio
CVI Holdings, LLC40,000$208.0K0.03%
JPMorgan Chase & Co1,110$6.00K0.00%

Sold out (23)

Institutions that held Palisade Bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.